Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Interaction between Lysozyme and a Phospholipid of Neoplastic Tissue (Oncolipin)

Abstract

LYSOZYME is a basic protein, tending to form complexes with fatty acids, aliphatic long-chain alcohols1, alkyl sulphates1,2, colic acids3, and cephalins4. Interaction promoted by lysozyme towards Rous sarcoma phosphatides is of particular interest5.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Smith, G., and Stocker, C., Arch. Biochem., 21, 383 (1949).

    CAS  PubMed  Google Scholar 

  2. Klotz, I. M., and Walker, F. M., Arch. Biochem., 18, 319 (1948).

    CAS  PubMed  Google Scholar 

  3. Caselli, P., Rass. Med. Sarda, 5, 389 (1954).

    CAS  Google Scholar 

  4. Brusca, A. E., and Patrono, D., Giorn. Batt. Virol. Imm., 53, 211 (1960).

    Google Scholar 

  5. Matracia, S., Allegra, D., and Salerno, A., Comm. Second Intern. Symp. Fleming's Lysozyme, Milan (1961).

  6. Aoyama, O., Gann, 50, Supp., 270 (1959).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

FERRARI, R., MATRACIA, S. Interaction between Lysozyme and a Phospholipid of Neoplastic Tissue (Oncolipin). Nature 192, 1187 (1961). https://doi.org/10.1038/1921187a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/1921187a0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing